Reperfusion Injury
Showing 1 - 25 of >10,000
Liver Ischemia-reperfusion Injury and Clinical Data Analysis
Recruiting
- Liver Injury
- No intervention
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 6, 2023
Reperfusion Injury, Myocardial Trial in Jakarta Pusat (Colchicine, Placebo (lactose))
Enrolling by invitation
- Reperfusion Injury, Myocardial
- Colchicine
- Placebo (lactose)
-
Jakarta Pusat, Jakarta, IndonesiaFakultas Kedokteran Universitas Indonesia
Feb 8, 2023
Myocardial Reperfusion Injury, Treatment Outcome, Prognosis Trial (Extracorporeal cardiac shock wave therapy(ECSW))
Not yet recruiting
- Myocardial Reperfusion Injury
- +3 more
- Extracorporeal cardiac shock wave therapy(ECSW)
- (no location specified)
Nov 12, 2022
Myocardial Reperfusion Injury Trial in Campinas (Pioglitazone 45 mg, Placebo)
Not yet recruiting
- Myocardial Reperfusion Injury
- Pioglitazone 45 mg
- Placebo
-
Campinas, SP, BrazilUniversity of Campinas
Mar 17, 2023
Myocardial Infarction, Reperfusion Injury, Myocardial Trial in Uxbridge (Transcoronary cooling and dilution, Standard of care)
Recruiting
- Myocardial Infarction
- Reperfusion Injury, Myocardial
- Transcoronary cooling and dilution
- Standard of care
-
Uxbridge, United KingdomHarefield Hospital
Nov 7, 2023
Ischemia-Reperfusion Injury Trial in Nantong (dexmedetomidine, Placebo)
Recruiting
- Ischemia-Reperfusion Injury
- dexmedetomidine
- Placebo
-
Nantong, Jiangsu, ChinaAffiliated Hospital Nantong University
Oct 27, 2022
Stroke Patients Trial in XI'an (Antihypertensive drugs (no restriction on the type of drugs))
Recruiting
- Stroke Patients
- Antihypertensive drugs (no restriction on the type of drugs)
-
XI'an, Shaanxi, ChinaXiJing hospital
Dec 26, 2022
Ischemic Reperfusion Injury Trial in Shijiazhuang City (Dexmedetomidine, 0.9% Sodium chloride, Tourniquet(Early))
Recruiting
- Ischemic Reperfusion Injury
- Dexmedetomidine
- +3 more
-
Shijiazhuang City, Hebei, China
- +1 more
Dec 13, 2022
Acute Ischemic Stroke, Reperfusion Injury Trial in Tianjin (Mechanical thrombectomy combined with ischemic post-conditioning)
Recruiting
- Acute Ischemic Stroke
- Reperfusion Injury
- Mechanical thrombectomy combined with ischemic post-conditioning
-
Tianjin, ChinaTianjin Huanhu Hospital
Jun 9, 2023
Coronary Artery Bypass Grafting, Coronary Artery Disease Trial (Melatonin, )
Not yet recruiting
- Coronary Artery Bypass Grafting
- Coronary Artery Disease
- Melatonin
- placebo
- (no location specified)
Sep 21, 2022
Vagus Nerve Stimulation, Acute Coronary Syndrome, Ischemia Reperfusion Injury Trial in Krasnodar (TENS)
Recruiting
- Vagus Nerve Stimulation
- +2 more
- TENS
-
Krasnodar, Russian FederationScientific Research Institute Ochapovsky Regional Clinical Hospi
Aug 7, 2023
Myocardial Infarction, Myocardial Ischemia, Myocardial Injury Trial in Philadelphia
Recruiting
- Myocardial Infarction
- +10 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 1, 2022
Ischemic Stroke, Acute, Ischemia-reperfusion Injury, Cerebral Edema Trial in Dongguan, Guangzhou (enzyme-linked immunosorbent
Recruiting
- Ischemic Stroke, Acute
- +2 more
- enzyme-linked immunosorbent assay(ELISA)
-
Dongguan, Guangdong, China
- +1 more
Oct 15, 2022
Ischemic Stroke, Revascularization, Endovascular Treatment Trial (Thermogard XP3)
Not yet recruiting
- Ischemic Stroke
- +3 more
- Thermogard XP3
- (no location specified)
Jan 10, 2023
Acute Ischaemic STROke: From LAboratory to the Patient's BED
Enrolling by invitation
- Acute Ischemic Stroke
- +4 more
- (no location specified)
Feb 10, 2023
Intermittent Hypoxia Trial in Austin (Intermittent hypoxia, Intermittent normoxia)
Active, not recruiting
- Intermittent Hypoxia
- Intermittent hypoxia
- Intermittent normoxia
-
Austin, TexasThe Unviersity of Texas at Austin
Jun 14, 2022
Kidney Transplantation, Ischemic Reperfusion Injury, Reperfusion Trial in Aktobe (Retrograde renal graft reperfusion,
Recruiting
- Kidney Transplantation
- +2 more
- Retrograde renal graft reperfusion
- Conventional antegrade renal graft reperfusion (without retrograde reperfusion)
-
Aktobe, KazakhstanWest Kazakhstan Medical University
Jan 6, 2022
Ischemia-reperfusion Injury Trial in Adelaide (BX-001N Part 1, BX-001N Part 2, Placebo)
Not yet recruiting
- Ischemia-reperfusion Injury
- BX-001N Part 1
- +2 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Oct 19, 2023
Myocardial Reperfusion Injury, Hypoxia, Hyperoxia Trial (Hypoxic-hyperoxic preconditioning, Placebo)
Completed
- Myocardial Reperfusion Injury
- +3 more
- Hypoxic-hyperoxic preconditioning
- Placebo
- (no location specified)
May 6, 2022
Ischemia Reperfusion Injury Trial in Philadelphia (Conjugated Estrogen, Normal saline)
Recruiting
- Ischemia Reperfusion Injury
- Conjugated Estrogen
- Normal saline
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 22, 2022
ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury Trial (Methylprednisolone, Isotonic
Not yet recruiting
- ST Elevation Myocardial Infarction
- +3 more
- Methylprednisolone
- Isotonic saline
- (no location specified)
Aug 4, 2022
Elective Percutaneous Coronary Intervention, Ischemic Reperfusion Injury Trial in Cairo (Metformin)
Active, not recruiting
- Elective Percutaneous Coronary Intervention
- Ischemic Reperfusion Injury
-
Cairo, Egypt
- +2 more
Jan 24, 2023
Ischemia-reperfusion Injury, Kidney Transplant; Complications Trial in Malmö (TUM012, Placebo)
Recruiting
- Ischemia-reperfusion Injury
- Kidney Transplant; Complications
- TUM012
- Placebo
-
Malmö, SwedenHelena Pollard
Apr 5, 2022
Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial Trial in Santiago de Chile (Antioxidant
Recruiting
- Acute Myocardial Infarction
- +4 more
- Antioxidant formula
- Dextrose 5% in water
-
Santiago de Chile, ChileUniversity of Chile
Jan 17, 2022